Earendil Labs
EL
EA

Earendil Labs

Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.

2024ActiveBeijing, China

About

Earendil Labs is an AI-powered biotechnology company advancing next-generation biologics for patients with autoimmune diseases, cancer, and other areas of significant unmet medical need. They integrate artificial intelligence across the full R&D lifecycle, from target identification and molecular design to optimization and clinical progression, to systematically generate and advance high-quality therapeutic programs.

Key facts

At-a-glance profile data

Headquarters
Beijing, China
Founded
2024
Total funding
$787M (Funding Round)
Business model
B2B
Tags
Biotechnology
Artificial Intelligence
Drug Discovery
Pharmaceuticals
AI Drug Discovery

Funding rounds

Funding rounds raised by Earendil Labs
DateRoundAmountLead investors
20 Mar 2026Funding Round$787MDimension, DST Global Partners, INCE Capital, Sanofi Ventures, Luminous Ventures, Miracle Capital, Vivo Capital
Add first review

Frequently asked

How much funding has Earendil Labs raised?

Earendil Labs has raised a total of $787M in funding. The most recent round on record is Funding Round.